Orchestra BioMed Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 25 shareholders own 61.18% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
16.4%	Medtronic plc	5,868,916	US$27.0m	0%	no data
15.7%	RTW Investments, LP	5,620,640	US$25.9m	0%	0.46%
6.8%	Perceptive Advisors LLC	2,432,089	US$11.2m	0%	0.27%
5.13%	Ascent Biomedical Ventures	1,834,783	US$8.4m	0%	100.0%
4.03%	BlackRock, Inc.	1,441,189	US$6.6m	-1.88%	no data
3.43%	The Vanguard Group, Inc.	1,228,347	US$5.7m	0.09%	no data
1.74%	T. Rowe Price Group, Inc.	622,608	US$2.9m	-0.32%	no data
1.71%	RA Capital Management, L.P.	610,283	US$2.8m	0%	0.04%
1.19%	Geode Capital Management, LLC	425,749	US$2.0m	2.42%	no data
0.8%	State Street Global Advisors, Inc.	285,910	US$1.3m	58.9%	no data
0.67%	Tavistock Life Sciences	238,193	US$1.1m	0%	0.07%
0.65%	David Hochman	231,823	US$1.1m	0%	no data
0.5%	Charles Schwab Investment Management, Inc.	179,710	US$826.7k	2.37%	no data
0.4%	Northern Trust Global Investments	142,879	US$657.3k	-1.13%	no data
0.36%	SVB Asset Management	127,068	US$584.5k	0%	0.36%
0.26%	TD Asset Management, Inc.	92,678	US$426.3k	0%	no data
0.23%	Darren Sherman	83,778	US$385.4k	0%	no data
0.21%	Michael Kaswan	76,511	US$352.0k	-52.9%	no data
0.18%	Jason Aryeh	62,984	US$289.7k	0%	no data
0.17%	Avenue Capital Group, LLC	60,869	US$280.0k	0%	0.24%
0.15%	HighTower Advisors, LLC	53,000	US$243.8k	231%	no data
0.14%	Arkadios Wealth Advisors LLC	51,595	US$237.3k	0%	0.02%
0.14%	Yuval Mika	49,572	US$228.0k	0%	no data
0.11%	Manulife Asset Management	39,942	US$183.7k	4.14%	no data
0.092%	BNY Mellon Asset Management	32,776	US$150.8k	-30.6%	no data